Key statistics
As of last trade Collegium Pharmaceutical Inc (354:FRA) traded at 35.00, -7.89% below its 52-week high of 38.00, set on Mar 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 35.00 |
---|---|
High | 35.00 |
Low | 35.00 |
Bid | 35.00 |
Offer | 35.40 |
Previous close | 34.80 |
Average volume | 4.29 |
---|---|
Shares outstanding | 32.21m |
Free float | 31.79m |
P/E (TTM) | 17.01 |
Market cap | 1.26bn USD |
EPS (TTM) | 2.30 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 07:14 BST.
More ▼
Announcements
- Collegium Completes Acquisition of Ironshore Therapeutics
- Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference
- Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024
- Collegium Reports Second Quarter 2024 Financial Results
- Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology
- Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024
- Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise
- Collegium to Participate in Jefferies Global Healthcare Conference
- Collegium Announces $35 Million Accelerated Share Repurchase Program
- Collegium Reports First Quarter 2024 Financial Results
More ▼